NAGE EBITDA Growth
Niagen Bioscience Inc · EBITDA Growth
NAGE EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-7.37%period ending
NAGE TTM EBITDA YoY % (-7449.48% → -7.37%)
Year-over-year change
High-resolution chart · PNG
NAGE ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -7.3671% | |
| 32.4314% | |
| 89.9797% | |
| 660.4558% | |
| 8,536.2445% | |
| 956.3801% | |
| 419.7959% | |
| 143.9211% | |
| 103.3607% | |
| 83.0083% | |
| 80.6916% | |
| 63.4692% | |
| 74.279% | |
| 57.0672% | |
| 34.2005% | |
| 29.0288% | |
| -22.6538% | |
| -29.8422% | |
| -38.7438% | |
| -23.8539% | |
| 9.3431% | |
| 27.5651% | |
| 38.4055% | |
| 27.7465% | |
| 23.5521% | |
| 14.9829% | |
| 7.8967% | |
| 11.066% | |
| -13.1436% | |
| -44.2456% | |
| -106.441% | |
| -263.564% | |
| -299.4843% | |
| -460.587% | |
| -768.9372% | |
| -851.4075% | |
| -5,215.7828% | |
| -796.4991% | |
| 0.9715% | |
| 43.9981% | |
| 105.2953% | |
| 88.981% | |
| 63.3887% | |
| 62.961% | |
| 50.9395% | |
| 11.9032% | |
| -20.7883% | |
| 9.4868% | |
| 2.7429% | |
| 44.9189% | |
| 63.5367% | |
| 57.9949% | |
| 58.718% | |
| 22.9574% | |
| -51.1872% | |
| -105.7142% | |
| -197.445% | |
| -282.7607% | |
| -358.0702% | |
| -588.3257% | |
| -2,706.6784% | |
| -1,836.3117% | |
| -227.1055% | |
| 15.832% | |
| 89.9466% | |
| 92.6651% | |
| 71.6843% | |
| 18.0469% | |
| -141.8013% | |
| -14,353.3285% | |
| -7,449.483% |